Report any abdominal pain, changes in bowel habits, or digestive symptoms immediately, as early intervention can prevent complications
According to the STEP 1 trial, which studied semaglutide for weight loss: Participants lost an average of 15% of their body weight over 68 weeks (1 year, 4 months)
Free radicals can cause cell damage
Drivers Rising Prevalence of Obesity and Related Metabolic Disorders The rising prevalence of obesity and related metabolic disorders is one of the key factors driving the growth of the GLP-1 targeted peptide weight loss drugs market
These have an anti-inflammatory effect and help in lightening dark spots, moisturizing skin, reducing hyperpigmentation, and stimulating skin renewal
When administering the medication, wash your hands thoroughly and use sterile techniques to prevent contamination